Shuttle Pharmaceuticals Stock Performance
| SHPH Stock | USD 2.02 0.17 7.76% |
The entity has a beta of 1.71, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Shuttle Pharmaceuticals will likely underperform. At this point, Shuttle Pharmaceuticals has a negative expected return of -0.25%. Please make sure to validate Shuttle Pharmaceuticals' value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Shuttle Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Shuttle Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
| Begin Period Cash Flow | 2.6 M | |
| Total Cashflows From Investing Activities | 2.9 M |
Shuttle Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 310.00 in Shuttle Pharmaceuticals on November 3, 2025 and sell it today you would lose (108.00) from holding Shuttle Pharmaceuticals or give up 34.84% of portfolio value over 90 days. Shuttle Pharmaceuticals is currently does not generate positive expected returns and assumes 9.4734% risk (volatility on return distribution) over the 90 days horizon. In different words, 85% of stocks are less volatile than Shuttle, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Shuttle Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of Shuttle Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.02 | 90 days | 2.02 | about 39.88 |
Based on a normal probability distribution, the odds of Shuttle Pharmaceuticals to move above the current price in 90 days from now is about 39.88 (This Shuttle Pharmaceuticals probability density function shows the probability of Shuttle Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.71 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Shuttle Pharmaceuticals will likely underperform. Additionally Shuttle Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Shuttle Pharmaceuticals Price Density |
| Price |
Predictive Modules for Shuttle Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Shuttle Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Shuttle Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Shuttle Pharmaceuticals is not an exception. The market had few large corrections towards the Shuttle Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Shuttle Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Shuttle Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.32 | |
β | Beta against Dow Jones | 1.71 | |
σ | Overall volatility | 0.39 | |
Ir | Information ratio | -0.03 |
Shuttle Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Shuttle Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Shuttle Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Shuttle Pharmaceuticals generated a negative expected return over the last 90 days | |
| Shuttle Pharmaceuticals has high historical volatility and very poor performance | |
| Shuttle Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Shuttle Pharmaceuticals currently holds 1.17 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Shuttle Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Shuttle Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (9.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Shuttle Pharmaceuticals currently holds about 50.44 K in cash with (7.33 M) of positive cash flow from operations. |
Shuttle Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Shuttle Stock often depends not only on the future outlook of the current and potential Shuttle Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Shuttle Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 10.3 M | |
| Cash And Short Term Investments | 1.9 M |
Shuttle Pharmaceuticals Fundamentals Growth
Shuttle Stock prices reflect investors' perceptions of the future prospects and financial health of Shuttle Pharmaceuticals, and Shuttle Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shuttle Stock performance.
| Return On Equity | -271.76 | |||
| Return On Asset | -3.23 | |||
| Current Valuation | 2.79 M | |||
| Shares Outstanding | 1.92 M | |||
| Price To Book | 3.02 X | |||
| EBITDA | (7.78 M) | |||
| Cash And Equivalents | 50.44 K | |||
| Total Debt | 1.17 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 1.13 X | |||
| Cash Flow From Operations | (7.33 M) | |||
| Earnings Per Share | (3.14) X | |||
| Total Asset | 2.51 M | |||
| Retained Earnings | (34.58 M) | |||
About Shuttle Pharmaceuticals Performance
By evaluating Shuttle Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Shuttle Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shuttle Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shuttle Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. The company was founded in 2012 and is based in Rockville, Maryland. Shuttle Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.Things to note about Shuttle Pharmaceuticals performance evaluation
Checking the ongoing alerts about Shuttle Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shuttle Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Shuttle Pharmaceuticals generated a negative expected return over the last 90 days | |
| Shuttle Pharmaceuticals has high historical volatility and very poor performance | |
| Shuttle Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Shuttle Pharmaceuticals currently holds 1.17 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Shuttle Pharmaceuticals has a current ratio of 0.03, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Shuttle Pharmaceuticals' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (9.14 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Shuttle Pharmaceuticals currently holds about 50.44 K in cash with (7.33 M) of positive cash flow from operations. |
- Analyzing Shuttle Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shuttle Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Shuttle Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shuttle Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shuttle Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shuttle Pharmaceuticals' stock. These opinions can provide insight into Shuttle Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Shuttle Stock analysis
When running Shuttle Pharmaceuticals' price analysis, check to measure Shuttle Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shuttle Pharmaceuticals is operating at the current time. Most of Shuttle Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Shuttle Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shuttle Pharmaceuticals' price. Additionally, you may evaluate how the addition of Shuttle Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |